Impact of Hemodilution on Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia

被引：0
|
作者：
Tettero, Jesse [1 ,2 ]
Heidinga, Maaike [1 ]
Mocking, Tim [1 ]
Kelder, Angele [1 ]
Scholten, Willemijn [1 ]
Snel, Alexander [1 ]
Ngai, Lok Lam [1 ]
Bachas, Costa [1 ]
van de Loosdrecht, Arjan [1 ]
Ossenkoppele, Gert [1 ]
de Leeuw, David [1 ]
Janssen, Jeroen [3 ]
Cloos, Jacqueline [1 ]
机构：
[1] Amsterdam UMC, Amsterdam, Netherlands
[2] Virginia Tech, FBRI Canc Res Ctr, Washington, DC USA
[3] Radboudumc, Nijmegen, Netherlands
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
AML; acute myeloid leukemia; hemodilution; measurable residual disease; MRD;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-348
引用
收藏
页码：S307 / S308
页数：2
相关论文
共 50 条
  • [41] 28-color single tube for flow cytometric assessment of myeloid maturation, myeloid neoplasia, and acute myeloid leukemia minimal/measurable residual disease
    Gao, Qi
    Chan, Alexander
    Zhang, Jingping
    Sun, Xiaotian
    Burke, Amanda
    Miu, Olivia
    Nguyen, Nghia
    Zhang, Shu Jie
    Reminick, Jennifer
    Wardrope, Jessica
    Roshal, Mikhail
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2025,
  • [42] Multidimensional flow cytometry for detection of minimal residual disease in acute myeloid leukemia
    Venditti, A
    Maurillo, L
    Buccisano, F
    Tamburini, A
    Del Poeta, G
    Del Principe, MI
    Panetta, P
    Consalvo, MI
    Mazzone, C
    Tendas, A
    Trawinska, M
    Forte, V
    Amadori, S
    LEUKEMIA & LYMPHOMA, 2003, 44 (03) : 445 - 450
  • [43] Computational assessment of measurable residual disease in acute myeloid leukemia using mixture models
    Mocking, Tim R.
    Kelder, Angele
    Reuvekamp, Tom
    Ngai, Lok Lam
    Rutten, Philip
    Gradowska, Patrycja
    van de Loosdrecht, Arjan A.
    Cloos, Jacqueline
    Bachas, Costa
    COMMUNICATIONS MEDICINE, 2024, 4 (01):
  • [44] Hematopoietic cell transplantation as treatment of patients with acute myeloid leukemia with measurable residual disease after consolidation therapy
    Appelbaum, Frederick R.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2018, 31 (04) : 405 - 409
  • [45] Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
    Stahl, Maximilian
    Derkach, Andriy
    Farnoud, Noushin
    Bewersdorf, Jan Philipp
    Robinson, Troy
    Famulare, Christopher
    Cho, Christina
    Devlin, Sean
    Menghrajani, Kamal
    Patel, Minal A.
    Cai, Sheng F.
    Miles, Linde A.
    Bowman, Robert L.
    Geyer, Mark B.
    Dunbar, Andrew
    Epstein-Peterson, Zachary D.
    McGovern, Erin
    Schulman, Jessica
    Glass, Jacob L.
    Taylor, Justin
    Viny, Aaron D.
    Stein, Eytan M.
    Getta, Bartlomiej
    Arcila, Maria E.
    Gao, Qi
    Barker, Juliet
    Shaffer, Brian C.
    Papadopoulos, Esperanza B.
    Gyurkocza, Boglarka
    Perales, Miguel-Angel
    Abdel-Wahab, Omar
    Levine, Ross L.
    Giralt, Sergio A.
    Zhang, Yanming
    Xiao, Wenbin
    Pai, Nidhi
    Papaemmanuil, Elli
    Tallman, Martin S.
    Roshal, Mikhail
    Goldberg, Aaron D.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (01) : 79 - 89
  • [46] Clustering and Kernel Density Estimation for Assessment of Measurable Residual Disease by Flow Cytometry
    Jacqmin, Hugues
    Chatelain, Bernard
    Louveaux, Quentin
    Jacqmin, Philippe
    Dogne, Jean-Michel
    Graux, Carlos
    Mullier, Francois
    DIAGNOSTICS, 2020, 10 (05)
  • [47] Prognostic value of multicenter flow cytometry harmonized assessment of minimal residual disease in acute myeloblastic leukemia
    Lacombe, Francis
    Campos, Lydia
    Allou, Kaoutar
    Arnoulet, Christine
    Delabarthe, Adrienne
    Dumezy, Florent
    Feuillard, Jean
    Genevieve, Franck
    Guerin, Estelle
    Guy, Julien
    Jouault, Helene
    Lepelley, Pascale
    Maynadie, Marc
    Solly, Francoise
    Ballon, Orianne Wagner
    Preudhomme, Claude
    Baruchel, Andre
    Dombret, Herve
    Ifrah, Norbert
    Bene, Marie C.
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (02) : 422 - 428
  • [48] Measurable residual disease in patients undergoing allogeneic transplant for acute myeloid leukemia
    Wong, Zoe C.
    Dillon, Laura W.
    Hourigan, Christopher S.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2023, 36 (02)
  • [49] Detection and management of acute myeloid leukemia measurable residual disease: is it standard of care?
    Paterno, Giovangiacinto
    Del Principe, Maria Ilaria
    Venditti, Adriano
    CURRENT OPINION IN HEMATOLOGY, 2020, 27 (02) : 81 - 87
  • [50] Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk Factors
    Ozdemir, Zehra Narli
    Sahin, Ugur
    Dalva, Klara
    Baltaci, Mehmet Akif
    Uslu, Atilla
    Ozturk, Cemaleddin
    Seval, Guldane Cengiz
    Toprak, Selami Kocak
    Yuksel, Meltem Kurt
    Topcuoglu, Pervin
    Arslan, Onder
    Ozcan, Muhit
    Beksac, Meral
    Ilhan, Osman
    Gurman, Gunhan
    Bozdag, Sinem Civriz
    TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 (02) : 111 - 118
12345